Antibodies isolated from the cerebrospinal fluid of the bone marrow of patients with MS had a 30–60 times higher activity in the hydrolysis of DNA, MBP, and oligosaccharides compared with antibodies from the blood of the same patients [37,38,39]. Here, MBP is linked to myeloid sarcoma.